A limited number of Escherichia coli isolates which produce an apparently novel toxin, termed cytolethal distending toxin (CDT), have been reported. The toxic activity produced by these strains causes certain cultured cell lines to become slowly distended and then disintegrate. DNA was isolated from the CDTproducing E. coli strain, 9142-88, and cloned into a cosmid vector. Plasmid DNA from a toxin-positive transductant was further subcloned until a plasmid with a 4-kb insert which still encoded the toxin activity was obtained. 
There are a few reports in the literature of an apparently novel toxin activity produced by a limited number of Escherichia coli isolates (2, 6, 8) , some Shigella isolates (7) , and many Campylobacterjejuni isolates (9) . This activity has been termed cytolethal distending toxin (CDT) because of the effect that the toxin has on certain cultured cells. For example, HeLa cells, Chinese hamster ovary cells, and Vero cells become slowly distended and then die when culture filtrates of CDT-positive strains are applied (6, 8) . The distention of these cultured cells is first visible 48 to 72 h after the toxin had been added to nonconfluent monolayers, and distention usually continues for another 24 to 48 h (8) . This pattern of distention and death is different from the effects of the E. coli heat-labile toxins, heat-stable toxins, and Shiga-like toxins on these cultured cell lines (8) 
There is no significant level of multinucleation accompanying the distention, which differentiates this effect from that of cytotoxic necrotizing factor (8) . The toxic effect is not neutralized by antisera to other E. coli toxins known to have effects on some of these cultured cell lines, such as the heat-labile toxins and Shiga-like toxins (8) . Nor does CDT appear to behave like other known E. coli toxins in various bioassays (8) . These observations clearly indicate that this activity is different from any other known E. coli toxins. CDT, does not, in fact appear to resemble the activity of any other well-studied bacterial toxin.
Johnson and Lior (8) further reported that CDT was most likely a protein, since the activity was heat sensitive (70°C, 15 min), trypsin sensitive, and nondialyzable. In two studies (2, 8) , over 3 ,000 E. coli strains were screened for the presence of CDT. No clear pattern of association of the toxin with particular serotypes has emerged. However, since the total number of strains that produced CDT within a given serogroup was always small, it is premature to try to correlate CDT produc-tion with particular serogroups. The CDT-positive strains were isolated from patients with a variety of symptoms (2, 8) , although generally some type of diarrheal disease or gastroenteritis was reported. We report here on the cloning, sequencing, and expression of cdt genes from an E. coli 0128:Hstrain.
MATERIALS AND METHODS
Bacterial strains and media. The CDT-producing E. coli 9142-88 (0128:H-), 3371-88 (050:H-), and 6468-62 (086: H34) were kindly provided by Nancy Strockbine of the Centers for Disease Control, Atlanta, Ga. The 0128 nonmotile strain was isolated from a 2-year-old child with diarrhea and has been described (6, 8) . Strain 3371-88 was taken from the throat of a 2-month-old boy with necrotizing enterocolitis and hyaline membrane disease, and strain 6468-62 was isolated from a 1-month-old child with diarrhea. E. coli DH5aMCR (GIBCO/ BRL, Gaithersburg, Md.) and E. coli HB101 were used as recipients in the cloning experiments. The E. coli minicellproducing strain P678-54 has been described (1). All strains were grown routinely on L medium (13) . When necessary, antibiotics were added to the following final concentrations (in micrograms per milliliter): ampicillin, 50; kanamycin, 25; and tetracycline, 25.
Plasmids. Cosmid pHC79 was described by Hohn and Collins (4), and cloning vector pK184 was described by Jobling and Holmes (5) . Plasmid pK184 contains a pi5a origin of replication, a multiple cloning site within the lacZ gene, and a kanamycin resistance gene, thereby allowing for easy isolation of subclones from the ampicillin-resistant cosmid clones. Plasmid pBluescript IISK-was obtained from Stratagene, La Jolla, Calif. Plasmid pCP3001 was derived during this work and is a cosmid clone consisting of the vector pHC79 and 45 kb of chromosomal DNA from E. coli 9142-88. Plasmid pCP3005 is a derivative of pCP3001 and contains only 13 kb of insert DNA. Plasmid pCP2100 consists of 4 kb of insert DNA derived from pCP3005 cloned into pK184. Further subclones of pCP2100 include pCP2105, pCP2108, pCP2109, pCP2161, E. COLI CYTOLETHAL DISTENDING TOXIN 1047 pCP2121, and pCP2123 and are described in Results, Table 1 , and Fig. 1 .
Toxin assay. The assay for CDT was based on the assay described by Johnson and Lior (8) . Assays were performed with cultured HeLa cells grown in Eagle's minimal essential medium supplemented with 10% fetal bovine serum, gentamicin (100 jig/ml), penicillin (50 U/ml), and streptomycin (50 ,ug/ml). 96-well microtiter plates were seeded with 1 x 103 to 2 x 103 HeLa cells per well, and when the nonconfluent cells were 18 h old, the assays were performed. Bacterial strains were grown overnight at 37°C in 1-ml samples of L broth, shaking at 225 rpm. The cells were pelleted, and when desired, the supernatant fraction was retained and filtered with a 0.22-,um-pore-size filter. The pellet was resuspended in 1 ml of the HeLa cell culture medium, and the suspension was sonicated in two 30-s bursts. Following sonication, the disrupted cells were centrifuged at 6,000 x g to remove unbroken cells. The resultant supernatant fraction was filtered as described above. Both culture supernatants and sonic lysates were assayed immediately. Toxin Fig. 2 . The three putative CDT ORFs are shown under the restriction map. Plasmids pCP2123, pCP2108, pCP2105, pCP2109, pCP2161, and pCP2121 were derived from pCP2100 and contain the DNA shown. Whether E. coli strains harboring these plasmids produced (+) active CDT or not (-) is indicated. Restriction endonuclease abbreviations: S, SspI; K, KpnI; Sn, SnaBI; E, EcoRI; and Sa, Sall.
compared. Culture supernatants from all three contained toxin activity, although none had titers greater than 8. Sonic lysates had much higher titers than did the culture supernatant fractions, with strain 9142-88 consistently exhibiting the highest titers (256 to 512).
A cosmid bank of DNA from strain 9142-88 was prepared by inserting into the BamHI site of pHC79, 40-to 45-kb Sau3A partial-digestion fragments of 9142-88 chromosomal DNA. Sonic lysates of 600 ampicillin-resistant transductants in E. coli HB101 were screened for toxin activity in the HeLa cell assay.
Plasmid DNA was prepared from the three CDT-positive clones that were identified. Restriction patterns of the three plasmids indicated that all three were different but that they contained some overlapping DNA. The CDT titer produced by the cosmid clones in HB101 was equivalent to that of strain 9142-88. Initial attempts to create small, strongly toxin-positive subclones with various restriction fragments derived from the cosmid clones were unsuccessful. An EcoRV deletion subclone, pCP3005, was CDT positive but still contained 13 kb of insert DNA. Subsequently, pCP3005 was partially digested with Sau3A, and fragments ranging from 3 to 9 kb were isolated and cloned into pK184. Several CDT-positive clones were obtained, the smallest of which, pCP2100, had a 4-kb insert.
The portion of pCP2100 most likely to encode CDT was identified by locating the sites of various restriction endonucleases that had failed to produce toxin-positive subclones. Figure  1 illustrates the portion of pCP2100 that was sequenced, and Fig. 2 
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CCATCTCCGCTACAAGCGGGAATTGTATATGGAGCCAGAAGAACTCAAATATCTTCAGATCATTTCCCTGTTGGCGTATCCAGACGATAAAAGGCTAT cdtA -a Determined from migration in SDS-polyacrylamide gels. b Symbols: +, the lac promoter present on the cloning vector is oriented such that it could promote transcription of the cdt genes; -, the lac promoter is not in the proper orientation to direct transcription of the cdt genes.
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would produce an appropriate sized leader sequence (see results of minicell experiments). The Met at position 10 is not preceded by a consensus ribosome binding site, and the resultant amino-terminal region of CdtC would no longer be predicted to contain a hydrophobic, cleavable leader sequence. ORF1 and ORF2 were also preceded by consensus ribosome binding sites (Fig. 2) , and their predicted proteins also appeared to have potential leader sequences (16) . The most probably cleavage sites for each leader are shown in Fig. 2 . Two sites are shown for the protein encoded by ORF3 and these may both be incorrect, since two other sites might also be possible (after Ser-17 and after Ser-19). In fact, these leader sequences were the only particularly hydrophobic regions of these proteins (data not shown).
Deletion analysis and minicell experiments. Several subclones were made from pCP2100 to establish that the three ORFs actually encoded appropriately sized proteins and to determine the necessity of the proteins for toxic activity. Several of the subclones, pCP2108, pCP2109, pCP2105, and pCP2161, were constructed by deletions of portions of pCP2100 and are shown in Fig. 1 . The other two subclones shown in Fig. 1, pCP2123 and pCP2121 , consist of the illustrated fragments inserted into the cloning vector pBluescript IISK-. A summary of all of these clones is provided in Table  1 . The smallest subclone which still produced CDT activity was pCP2123, indicating that at most all three of the sequenced ORFs are required for activity and that none of the DNA flanking these three ORFs in pCP2100 is required for toxic activity. Figure 3 shows the results of a minicell experiment in which the proteins produced by several of the subclones are compared with those produced by pCP2100. Lane 3 represents the proteins encoded by pCP2100. Proteins unique to pCP2100, that is, not encoded by the vector, pK184 (lane 2), are indicated by the arrowheads in lanes 4 and 6 and have apparent molecular weights of 51,000, 35,500, 32,500, 32,000, 30,500, 22,000, and 21,500. Plasmid pCP2105 ( Fig. 1; Fig. 3 , lane 5) contained only one intact cdt gene, ORF3, was no longer capable of producing CDT, and produced only the two smallest proteins of 22.0 and 21.5 kDa, clearly indicating that ORF3 most likely encoded the 22.0-and 21.5-kDa proteins. Plasmid pCP2108 ( Fig. 1; Fig. 3 , lane 6) contained two intact cdt genes, ORF2 and ORF3, and produced the 32.0-, 30.5-, 22.0-, and 21.5-kDa proteins. This result, in conjunction with the result for pCP2105, indicated that ORF2 encodes the 32.0-and 30.5-kDa proteins. Plasmid pCP2109 ( Fig. 1; Fig. 3, lane 4) contains an intact ORF1 with the flanking upstream DNA. This plasmid encoded the 51.0-, 35.5-, and 32.5-kDa proteins. Plasmid pCP2161 ( Fig. 1; Fig. 3 genes but did contain the DNA upstream of ORF1. This clone produced only the 51.0-kDa protein, indicating that this protein is not encoded by the three CDT ORFs but is instead encoded by an upstream gene that was not sequenced. This result, along with the result from pCP2109, indicated that ORF1 encodes the 35.5-and 32.5-kDa proteins.
These minicell results are also in agreement with the sequence data which predicted that all three ORFs contain leader sequences that are likely to be cleaved during the secretion process. In each case, a doublet of proteins was seen to be present or absent in the various plasmid-containing minicells, and the different sizes of the two proteins were consistent with the sizes of the predicted leader peptides.
The sizes of the proteins encoded by ORF2 and ORF3 were in fairly close agreement with their apparent sizes determined from SDS-polyacrylamide gel electrophoresis. However, the product of ORF1 had a predicted molecular weight of 27,753 yet migrated with an apparent molecular weight of 35,500. To verify that ORF1 encoded the 35.5-and 32.5-kDa proteins, another subclone, pCP2121, was made in which the intact ORF1 was inserted into pBluescript (Fig. 1) . This would also confirm that a protein with a molecular weight of about 28,000 was not produced by this ORF. (A 28-kDa protein could be present in pCP2100 and its pK184-based derivatives but would not be visible because of the large protein band that is the product of the kanamycin resistance gene [Fig. 3, lane 2] ). The results with pCP2121 clearly indicated that no 28-kDa proteins were present and that a protein with an apparent size of 35.5 kDa was present (data not shown). In summary, the products of the three sequenced ORFs were visualized and identified in the minicell experiments.
The minicell experiments also indicated that expression of the cdt genes was independent of the orientation of the clones within the vectors. That is, the orientation of the cdt genes relative to the lac promoter in pCP2100 is the reverse of the orientation of the cdt genes relative to the lac promoter in pCP2123 (Table 1 ). Yet pCP2121 and with pCP2108, which carries intact cdtB and cdtC genes. In this case E. coli cells carrying these two plasmids were CDT positive. These results indicated that CdtB is required for CDT activity. The second experiment involved making deletions into cdtC. PstI, which cuts in the multiple cloning site of pK184 downstream of cdtC, was used to linearize pCP2100. Nuclease BAL 31-generated deletion derivatives of pCP2100 were subsequently made and analyzed for their DNA content and their ability to product CDT. Deletions which extended into cdtC did not produce CDT activity. DNA sequencing of two deletion endpoints confirmed that the deletions extended into cdtC, but not into cdtB.
DISCUSSION
The experiments presented here indicate that CDT is indeed a novel toxin: its primary sequence is unlike that of any of the well-studied bacterial toxins. We have shown that CDT is encoded by three adjacent or slightly overlapping genes all of which are required for toxin activity. These three genes, cdtA, cdtB, and cdtC, may constitute an operon, since they are close together and there are no other nearby ORFs on either strand, either upstream or downstream of these three genes. The coding region encompassed by cdtA, cdtB, and cdtC (2,142 bp) is in close agreement with the approximately 2,100-bp sequence reported by Scott and Kaper (18) to be required for CDT activity.
The minicell and deletion experiments conclusively showed that the three ORFs encoded proteins of approximately the expected size. Each protein appeared to have a leader sequence for secretion, which was only partially cleaved in the minicells. It is of interest to note that one of the indicated cleavage sites for the leader sequence of the protein encoded by cdtC (after Gly-15) has the characteristics of a cleavage site for a lipoprotein (16) . If the CdtC protein is a lipoprotein, it is presumably secreted past the cytoplasmic membrane, since there is no Asp residue at +2 to act as a sorting signal for delivery of lipoproteins to the cytoplasmic membrane (16, 20) . We have been developing a purification procedure for CDT from both C. jejuni and E. coli, and we have found that CDTs from both organisms behave similarly, and in particular, both act as if they were extremely hydrophobic proteins (14) . However, hydrophobicity analysis of the three predicted CDT proteins from E. coli does not indicate any hydrophobic regions other than the leader sequences (data not shown). We are currently investigating the possibility that one of the CDT proteins is a lipoprotein. The presence of the leader sequences is consistent with the finding that CDT activity is present in culture supernatants. Yet, substantial amounts of CDT activity remain cell associated in both E. coli and C. jejuni. Therefore, it is not clear whether CDT is secreted outside the cell or whether the toxin remains associated with the outer membrane and is shed in blebs.
Neither the function of the individual Cdt proteins nor the precise effect of the toxin on cultured cells is known. Also, it is not clear what role CDT might have in pathogenesis. The isolation of the cdt genes now makes it possible to pursue meaningful answers to these questions.
